Package 68998-018-11

{"route": ["ORAL"], "spl_id": "401f8cd0-5b2e-d6b0-e063-6394a90ad8e8", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0099581910426"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["14cb1d2d-95b8-447e-8d79-e6ec82c0e431"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Marc Glassman, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (68998-018-11)  / 100 TABLET, COATED in 1 BOTTLE, PLASTIC", "package_ndc": "68998-018-11", "marketing_start_date": "20091101"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (68998-018-14)  / 300 TABLET, COATED in 1 BOTTLE, PLASTIC", "package_ndc": "68998-018-14", "marketing_end_date": "20271030", "marketing_start_date": "20091101"}], "brand_name": "ASPIRIN", "product_id": "68998-018_401f8cd0-5b2e-d6b0-e063-6394a90ad8e8", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "68998-018", "generic_name": "ASPIRIN", "labeler_name": "Marc Glassman, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20091101", "listing_expiration_date": "20261231"}